𝐋𝐨𝐨𝐤𝐢𝐧𝐠 𝐛𝐚𝐜𝐤 𝐚𝐭 𝐥𝐢𝐟𝐞 - the biomedical convention 𝟐𝟎𝟐𝟔:
𝐂𝐨𝐧𝐧𝐞𝐜𝐭𝐢𝐧𝐠 𝐭𝐡𝐞 𝐥𝐢𝐟𝐞 𝐬𝐜𝐢𝐞𝐧𝐜𝐞 𝐞𝐜𝐨𝐬𝐲𝐬𝐭𝐞𝐦 𝐚𝐜𝐫𝐨𝐬𝐬 𝐫𝐞𝐠𝐢𝐨𝐧𝐬
Heidelberg,4th Feb: 500 participants from academia, startups, industry, investment and policy made life a central platform for exchange, translation and collaboration.
#life2026
#life2027

𝗪𝗼𝗿𝗸𝗶𝗻𝗴 𝗼𝗻 𝗻𝘂𝗰𝗹𝗲𝗶𝗰 𝗮𝗰𝗶𝗱 𝗾𝘂𝗮𝗻𝘁𝗶𝗳𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗹𝗼𝗼𝗸𝗶𝗻𝗴 𝗳𝗼𝗿 𝗮𝗰𝗰𝘂𝗿𝗮𝗰𝘆 𝗯𝗲𝘆𝗼𝗻𝗱 𝘁𝗵𝗲 𝗹𝗶𝗺𝗶𝘁𝘀 𝗼𝗳 𝘁𝗿𝗮𝗱𝗶𝘁𝗶𝗼𝗻𝗮𝗹 𝗣𝗖𝗥 𝗺𝗲𝘁𝗵𝗼𝗱𝘀?

Join the 𝘀𝗺𝗮𝗿𝘁𝗟𝗮𝗯𝘀 𝗦𝘂𝗺𝗺𝗶𝘁 𝟮𝟬𝟮𝟱
🗓 𝗪𝗵𝗲𝗻: 24 September 2025
⏰ 𝗧𝗶𝗺𝗲: 1:00 PM – 7:30 PM
📍 𝗪𝗵𝗲𝗿𝗲: @BioLabs Heidelberg
🎟 𝗙𝗿𝗲𝗲 𝗿𝗲𝗴𝗶𝘀𝘁𝗿𝗮𝘁𝗶𝗼𝗻: bit.ly/3GSQFse

Big news in research & biotech!
📜Stem cell-like cells drive pediatric blood cancer relapse (KiTZ, MMPU & DKFZ).
🚀BioLabs | TUM launches in Munich
💰DFG funds “DynOrg” at Heidelberg University to explore GPCR signaling in adaptation.

#Biotech #Research #PediatricCancer #Munich #Heidelberg

𝐬𝐦𝐚𝐫𝐭𝐋𝐚𝐛𝐬 𝐒𝐮𝐦𝐦𝐢𝐭 𝟐𝟎𝟐𝟓 - 𝐎𝐩𝐭𝐢𝐦𝐢𝐬𝐞 𝐲𝐨𝐮𝐫 𝐰𝐨𝐫𝐤𝐟𝐥𝐨𝐰
Whether you’re exploring cutting-edge lab tech, smart automation tools, or digital lab solutions this summit is where innovation meets action.

🗓 24.09.25
🕐 1:00 -7:30 PM
📍BioLabs Heidelberg
AGENDA : lnkd.in/eu5UVp7y
REGISTER NOW: bit.ly/4lePwdE

𝗔𝗿𝗲 𝘆𝗼𝘂 𝗿𝗲𝗮𝗱𝘆 𝘁𝗼 𝗿𝗲𝘁𝗵𝗶𝗻𝗸 𝗹𝗮𝗯 𝘄𝗼𝗿𝗸𝗳𝗹𝗼𝘄𝘀?
𝗝𝗼𝗶𝗻 𝘂𝘀 𝗮𝘁 𝘁𝗵𝗲 𝗳𝗶𝗿𝘀𝘁-𝗲𝘃𝗲𝗿 𝘀𝗺𝗮𝗿𝘁𝗟𝗮𝗯𝘀 𝗦𝘂𝗺𝗺𝗶𝘁 𝟮𝟬𝟮𝟱!
𝗕𝘂𝘁 𝘁𝗵𝗮𝘁’𝘀 𝗷𝘂𝘀𝘁 𝘁𝗵𝗲 𝗯𝗲𝗴𝗶𝗻𝗻𝗶𝗻𝗴.
Workflow optimization is the focus – and we’re bringing in the experts on stage and on the expo floor:

𝗿𝗲𝗴𝗶𝘀𝘁𝗲𝗿 here👉https://biorn.org/news-events/smartlabs-summit-2025/

𝐋𝐢𝐟𝐞 𝐰𝐢𝐭𝐡 𝐭𝐰𝐨 𝐗 𝐜𝐡𝐫𝐨𝐦𝐨𝐬𝐨𝐦𝐞𝐬: agneseloda.bsky.social at bioRN Lounge:

💡 Women are incredibly variable thanks to inactivation of X chromosome
💡 Xist RNA could regulate dosage of Xlinked genes throughout life
💡 Natural fluctuations in Xist RNA could influence protein dosage in women.

bit.ly/43pSDaI

𝐛𝐢𝐨𝐑𝐍 𝐌𝟐𝐌 𝐟𝐞𝐚𝐭𝐮𝐫𝐢𝐧𝐠 𝐁𝐢𝐨𝐓𝐡𝐫𝐮𝐬𝐭
WHEN: 3 June , 12:00-12:40 pm
WHERE: digital via zoom
Register here: biorn.org/news-events/...

🌟 Happy Saturday with the Hioghlights of the Week! 🌟

UKHD x Mannheim merger clears hurdle: bit.ly/43lTMRU
VERAXA + OmniAb join forces on cancer therapy: bit.ly/3Z9tHD2
Childhood brain tumors traced to early nerve cells: bit.ly/3F2ba4W

More: bit.ly/3Yd5fPR

🎸 bioRN busy in Basel

2nd day rocking the floor at the Swiss Biotech Days together with our members Heidelberg Pharma AG; Sciomics: AGC Biologics; BIMOVIS and Trans-Duodenal Concepts GmbH.
Not in Basel? 👉 Join us at one of our next events: lnkd.in/e69jHZcw

𝐖𝐡𝐢𝐜𝐡 𝐩𝐚𝐭𝐡𝐬 𝐰𝐢𝐥𝐥 𝐥𝐞𝐚𝐝 𝐆𝐞𝐫𝐦𝐚𝐧 𝐛𝐢𝐨𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐭𝐨 𝐬𝐮𝐜𝐜𝐞𝐬𝐬?
𝐄𝐘 𝐆𝐞𝐫𝐦𝐚𝐧 𝐁𝐢𝐨𝐭𝐞𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 𝟐𝟎𝟐𝟓 𝐑𝐨𝐚𝐝𝐬𝐡𝐨𝐰
German Biotech Report - Swiss Biotech Report - bioRN facts and figures
📍When: May 22, 4:00–5:30 PM
📍 Where: Business Development Center (BDC), Heidelberg
✅ Register here: biorn.org/news-events/...

Highlights of the bioRN Life Science Cluster in the Rhine-Neckar region

🌟Highlights of the week🌟

📜 Preventing Defective Protein Blueprints: bit.ly/43zzgxO
🚀 Robot navigates precisely to changes in the lungs: bit.ly/42hJwZ8
🏆 Heinz Maier-Leibnitz Prize for Lukas Bunse: bit.ly/42h4s2m

👉 Find all news and much more in our newslounge at bioRN website: bit.ly/3Yd5fPR

𝐅𝐚𝐬𝐭 𝐚𝐧𝐝 𝐅𝐚𝐢𝐫 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐀𝐜𝐜𝐞𝐬𝐬 𝐭𝐨 𝐒𝐭𝐮𝐝𝐢𝐞𝐬 𝐚𝐧𝐝 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧
The bioRN Lounge had the great honor of hosting Ursula Weyrich for an insightful presentation on
@dkfz.bsky.social and its Clinical Research Network @nct-heidelberg.bsky.social.
▶️ Missed it? Register for next lnkd.in/eAvUMFVX

𝐖𝐚𝐭𝐜𝐡 𝐭𝐡𝐞 𝐧𝐞𝐰 𝐌𝟐𝐌 𝐢𝐧𝐭𝐞𝐫𝐯𝐢𝐞𝐰 𝐰𝐢𝐭𝐡 𝐨𝐮𝐫 𝐦𝐞𝐦𝐛𝐞𝐫 𝐀𝐫𝐜𝐨𝐧𝐝𝐢𝐬
- 𝐧𝐨𝐰 𝐚𝐯𝐚𝐢𝐥𝐚𝐛𝐥𝐞 𝐨𝐧 𝐝𝐞𝐦𝐚𝐧𝐝

🎦https://lnkd.in/ekWjHq_A

M2M – Member to member’ showcases bioRN companies, institutions, and players in the network.
Find more information about the upcoming bioRN M2M interviews at lnkd.in/e69jHZcw

𝐉𝐨𝐢𝐧 𝐮𝐬 𝐚𝐭 𝐭𝐡𝐞 𝐛𝐢𝐨𝐑𝐍 𝐕𝐢𝐥𝐥𝐚𝐠𝐞 𝐚𝐧𝐝 𝐞𝐱𝐩𝐥𝐨𝐫𝐞 𝐭𝐡𝐞 𝐯𝐢𝐛𝐫𝐚𝐧𝐭 𝐡𝐞𝐚𝐫𝐭 💚 𝐨𝐟 𝐥𝐢𝐟𝐞 𝐬𝐜𝐢𝐞𝐧𝐜𝐞𝐬 𝐢𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 - 𝐆𝐞𝐫𝐦𝐚𝐧 𝐁𝐢𝐨𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐃𝐚𝐲𝐬 𝟐𝟎𝟐𝟓
Visit the German Biotechnology Days,
9-10 April 2025, Heidelberg Congress Center
Registration: www.german-biotech.day/registration...

𝑯𝒊𝒈𝒉𝒍𝒊𝒈𝒉𝒕𝒔 𝒐𝒇 𝒕𝒉𝒆 𝑾𝒆𝒆𝒌!

📜 AI detects developmental disorders early by analyzing baby movements
🚀 NMI TT in Reutlingen and partners develop a precise method to analyze circulating tumor cells
🏆 Frank Winkler receives the Brain Prize 2025

👉 More the news and much more here bit.ly/3Yd5fPR

🌟 bioRN Highlights 🌟

📜 A special puppeteer holds the strings to liver cells’ identityhttps://bit.ly/3D4ILKt
💰 Funding for globally accessible rapid identification of tumor cells bit.ly/4kaA8ik
🚀BioMed X Institute Launches New Institute in Barbadoshttps://bit.ly/3QwmJU9
👉more news: bit.ly/3Yd5fPR

𝑯𝒊𝒈𝒉𝒍𝒊𝒈𝒉𝒕𝒔 𝒐𝒇 𝒕𝒉𝒆 𝑾𝒆𝒆𝒌!

When Cancer Cells Escape the Bone Marrow, Dangerous Diversity Emerges
bit.ly/3QjGLku

How the HIV-1 Capsid Breaches the Human Nucleus Barrier: bit.ly/4k0HIM6

Therapeutic Designer Peptide to Combat Acute Heart Muscle Weakness. bit.ly/4jYGQHR

>bioRN newslounge bit.ly/3Yd5fPR

𝗯𝗶𝗼𝗥𝗡 𝗩𝗶𝗹𝗹𝗮𝗴𝗲 at the German Biotechnology Days.

Showcasing our vibrant life science ecosystem, the scientific excellence, startup friendliness and high industry density!
👉 Register now and be part of the highlight event in Heidelberg: www.german-biotech.day

Yesterday we had the pleasure of welcoming Peter Loskill (@MicroOrgano-Lab) at the first bioRN Lounge with his impuls on >>𝐎𝐫𝐠𝐚𝐧-𝐨𝐧-𝐂𝐡𝐢𝐩: 𝐍𝐞𝐱𝐭-𝐆𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐡𝐮𝐦𝐚𝐧 𝐌𝐨𝐝𝐞𝐥 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐟𝐨𝐫 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐚𝐧𝐝 𝐩𝐞𝐫𝐬𝐨𝐧𝐚𝐥𝐢𝐳𝐞𝐝 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞<<.
Stay tuned about the bioRN events: biorn.org/news-events/...

Highlights of last week:

🚀 BioChatter: making large language models accessible for biomedical research
bit.ly/3EiRaKp
📜 How the Ebola virus multiplies in cells
bit.ly/4gb0NIr
🏆 New weapons against viruses
bit.ly/4arRnHn
👉 Find all news in our newslounge at bioRN website: bit.ly/3Yd5fPR

📜 HI-STEM: New study investigates how circulating tumor cells drive metastasis in breast cancer.
📜 Exploration of Novel Biomarkers for Neurodegenerative Diseases Using Proteomic Analysis and Ligand-Binding Assays
🚀BioMed X and Daiichi Sankyo collaborate in Cancer Therapy

biorn.org/news-events/...

𝟖 𝐬𝐞𝐜𝐨𝐧𝐝𝐬 𝐭𝐨 𝐬𝐭𝐚𝐧𝐝 𝐨𝐮𝐭 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐜𝐫𝐨𝐰𝐝 - 𝐭𝐡𝐞 𝐭𝐡𝐞 𝐚𝐫𝐭 𝐨𝐟 𝐬𝐜𝐢𝐞𝐧𝐭𝐢𝐟𝐢𝐜 𝐬𝐭𝐨𝐫𝐲𝐭𝐞𝐥𝐥𝐢𝐧𝐠
bioRN showcased Nanobot in an interview within the M2M Member to Member format: 🎦: biorn.org/news-events/...

M2M showcases bioRN companies, institutions, and players in the network.